James R Bell Selected Research

Glucose (Dextrose)

1/2017	Insights into the role of maladaptive hexosamine biosynthesis and O-GlcNAcylation in development of diabetic cardiac complications.
1/2013	Myocardial insulin resistance, metabolic stress and autophagy in diabetes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

James R Bell Research Topics

Disease

12	Ischemia 01/2022 - 03/2003
4	Heart Failure 01/2023 - 09/2013
3	Obesity 04/2024 - 10/2017
3	Diabetic Cardiomyopathies 03/2024 - 09/2013
3	Fibrosis (Cirrhosis) 11/2023 - 06/2011
3	Cardiomegaly (Heart Hypertrophy) 06/2017 - 01/2013
3	Insulin Resistance 01/2017 - 06/2011
3	Opioid-Related Disorders (Opiate Addiction) 09/2009 - 07/2004
2	Glucose Intolerance 04/2024 - 06/2011
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 09/2013
2	Cardiac Arrhythmias (Arrythmia) 12/2019 - 12/2011
2	Reperfusion Injury 11/2015 - 11/2014
2	Infarction (Infarctions) 12/2013 - 09/2013
2	Cardiomyopathies (Cardiomyopathy) 01/2013 - 06/2011
1	Breast Neoplasms (Breast Cancer) 01/2023
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 01/2023
1	Neoplasms (Cancer) 01/2023
1	Second Primary Neoplasms (Neoplasms, Second) 01/2023
1	Cardiotoxicity 01/2023
1	Myocardial Infarction 01/2022
1	Inflammation (Inflammations) 01/2022
1	Myocardial Ischemia (Ischemic Heart Diseases) 01/2022
1	Heart Diseases (Heart Disease) 01/2017
1	Diabetes Complications 01/2017
1	Contracture 11/2015
1	Myocardial Stunning (Stunned Myocardium) 11/2014
1	Heart Injuries 01/2014
1	Hypertrophy 09/2013
1	Type 2 Diabetes Mellitus (MODY) 01/2013
1	Rupture 08/2012
1	Ventricular Tachycardia 08/2012
1	Hyperglycemia 06/2011
1	Opiate Overdose 09/2009
1	Alcoholism (Alcohol Abuse) 10/2006
1	Heroin Dependence (Heroin Abuse) 07/2004

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 06/2017 - 01/2004
5	Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA 04/2015 - 08/2012
4	Estrogens (Estrogen)FDA Link 01/2019 - 09/2013
4	Aromatase (CYP19)IBA 10/2017 - 12/2011
3	SteroidsIBA 04/2015 - 09/2013
2	MineralocorticoidsIBA 01/2022 - 11/2015
2	Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA 01/2022 - 11/2015
2	Glucose (Dextrose)FDA LinkGeneric 01/2017 - 01/2013
2	SodiumIBA 11/2015 - 03/2003
2	Calmodulin (Calcium-Dependent Activator Protein)IBA 11/2015 - 02/2015
2	Testosterone (Sustanon)FDA Link 05/2014 - 09/2013
2	Insulin (Novolin)FDA Link 01/2013 - 06/2011
2	FructoseIBA 01/2013 - 06/2011
2	Naltrexone (ReVia)FDA LinkGeneric 10/2006 - 07/2004
2	Adenosine Triphosphatases (ATPase)IBA 01/2004 - 03/2003
1	SugarsIBA 04/2024
1	GlycogenIBA 03/2024
1	LipidsIBA 11/2023
1	AnthracyclinesIBA 01/2023
1	Dexrazoxane (Zinecard)FDA LinkGeneric 01/2023
1	Hormones (Hormone)IBA 01/2019
1	Lipocalin-2IBA 06/2017
1	HexosaminesIBA 01/2017
1	Adrenergic Agents (Adrenergic Drugs)IBA 01/2016
1	Omega-6 Fatty Acids (Omega 6 Fatty Acids)IBA 01/2016
1	Protein Kinases (Protein Kinase)IBA 11/2015
1	HydrogenIBA 11/2015
1	Phosphotransferases (Kinase)IBA 02/2015
1	Calcium-Calmodulin-Dependent Protein KinasesIBA 01/2014
1	p38 Mitogen-Activated Protein KinasesIBA 12/2013
1	ProdrugsIBA 12/2013
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 12/2013
1	JNK Mitogen-Activated Protein KinasesIBA 12/2013
1	KN 93IBA 08/2012
1	Buprenorphine (Subutex)FDA LinkGeneric 09/2009
1	Methadone (Dolophine)FDA LinkGeneric 09/2009
1	Opioid Analgesics (Opioids)IBA 08/2009
1	Narcotic Antagonists (Opioid Antagonists)IBA 08/2009
1	Naloxone Drug Combination Buprenorphine FDA Link 08/2009
1	Acamprosate (Campral)FDA Link 10/2006
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 10/2004
1	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2004
1	S-Nitroso-N-AcetylpenicillamineIBA 10/2004
1	DisulfidesIBA 10/2004
1	EnzymesIBA 01/2004
1	phospholemmanIBA 01/2004
1	StaurosporineIBA 01/2004
1	N- (2- (4- bromocinnamylamino)ethyl)- 5- isoquinolinesulfonamide (h89)IBA 01/2004
1	Protons (Proton)IBA 03/2003
1	Oxidants (Oxidizing Agents)IBA 03/2003

Therapy/Procedure

5	Therapeutics 03/2024 - 09/2013
2	Secondary Prevention 10/2006 - 07/2004
1	Drug Therapy (Chemotherapy) 01/2023